vs
Beta Bionics, Inc.（BBNX）与RIVERVIEW BANCORP INC（RVSB）财务数据对比。点击上方公司名可切换其他公司
Beta Bionics, Inc.的季度营收约是RIVERVIEW BANCORP INC的2.0倍（$27.6M vs $14.0M），RIVERVIEW BANCORP INC净利率更高（9.8% vs -79.3%，领先89.1%），Beta Bionics, Inc.同比增速更快（56.6% vs 10.4%）
Beta Bionics是一家专注于糖尿病管理领域的医疗科技企业，核心产品为iLet仿生胰腺，这款可穿戴设备可自动调节胰岛素与胰高血糖素的输送，服务1型和2型糖尿病患者，目前主要面向美国医疗市场，正规划推进全球业务布局。
Riverview Bancorp Inc.是一家总部位于美国的银行控股公司，主营个人与商业银行业务，服务覆盖太平洋西北地区，提供存款、消费贷款、住房抵押贷款、商业信贷及小企业金融等产品，服务零售客户与本地企业群体。
BBNX vs RVSB — 直观对比
营收规模更大
BBNX
是对方的2.0倍
$14.0M
营收增速更快
BBNX
高出46.2%
10.4%
净利率更高
RVSB
高出89.1%
-79.3%
损益表 — Q1 FY2026 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $27.6M | $14.0M |
| 净利润 | $-21.9M | $1.4M |
| 毛利率 | 59.5% | — |
| 营业利润率 | -47.4% | 12.4% |
| 净利率 | -79.3% | 9.8% |
| 营收同比 | 56.6% | 10.4% |
| 净利润同比 | 23.6% | 11.8% |
| 每股收益（稀释后） | $-0.49 | $0.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BBNXRVSB
| Q1 26 | $27.6M | — | ||
| Q4 25 | $32.1M | $14.0M | ||
| Q3 25 | $27.3M | $13.6M | ||
| Q2 25 | $23.2M | $13.3M | ||
| Q1 25 | $17.6M | $12.9M | ||
| Q4 24 | — | $12.7M | ||
| Q3 24 | — | $12.8M | ||
| Q2 24 | — | $12.2M |
净利润BBNXRVSB
| Q1 26 | $-21.9M | — | ||
| Q4 25 | $-13.5M | $1.4M | ||
| Q3 25 | $-14.2M | $1.1M | ||
| Q2 25 | $-16.9M | $1.2M | ||
| Q1 25 | $-28.7M | $1.1M | ||
| Q4 24 | — | $1.2M | ||
| Q3 24 | — | $1.6M | ||
| Q2 24 | — | $966.0K |
毛利率BBNXRVSB
| Q1 26 | 59.5% | — | ||
| Q4 25 | 59.0% | — | ||
| Q3 25 | 55.5% | — | ||
| Q2 25 | 53.8% | — | ||
| Q1 25 | 50.9% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
营业利润率BBNXRVSB
| Q1 26 | -47.4% | — | ||
| Q4 25 | -50.2% | 12.4% | ||
| Q3 25 | -62.5% | 10.2% | ||
| Q2 25 | -85.5% | 11.7% | ||
| Q1 25 | -105.7% | 11.3% | ||
| Q4 24 | — | 12.4% | ||
| Q3 24 | — | 15.5% | ||
| Q2 24 | — | 10.0% |
净利率BBNXRVSB
| Q1 26 | -79.3% | — | ||
| Q4 25 | -41.9% | 9.8% | ||
| Q3 25 | -52.1% | 8.1% | ||
| Q2 25 | -72.6% | 9.2% | ||
| Q1 25 | -162.5% | 8.9% | ||
| Q4 24 | — | 9.7% | ||
| Q3 24 | — | 12.2% | ||
| Q2 24 | — | 7.9% |
每股收益（稀释后）BBNXRVSB
| Q1 26 | $-0.49 | — | ||
| Q4 25 | $-0.16 | $0.07 | ||
| Q3 25 | $-0.33 | $0.05 | ||
| Q2 25 | $-0.39 | $0.06 | ||
| Q1 25 | $-0.93 | $0.05 | ||
| Q4 24 | — | $0.06 | ||
| Q3 24 | — | $0.07 | ||
| Q2 24 | — | $0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $199.5M | $28.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $271.2M | $164.2M |
| 总资产 | $304.4M | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BBNXRVSB
| Q1 26 | $199.5M | — | ||
| Q4 25 | $219.1M | $28.6M | ||
| Q3 25 | $228.7M | $32.8M | ||
| Q2 25 | $249.7M | $34.2M | ||
| Q1 25 | $231.5M | $29.4M | ||
| Q4 24 | — | $25.3M | ||
| Q3 24 | — | $31.0M | ||
| Q2 24 | — | $27.8M |
股东权益BBNXRVSB
| Q1 26 | $271.2M | — | ||
| Q4 25 | $287.6M | $164.2M | ||
| Q3 25 | $294.8M | $163.5M | ||
| Q2 25 | $301.6M | $162.0M | ||
| Q1 25 | $313.8M | $160.0M | ||
| Q4 24 | — | $158.3M | ||
| Q3 24 | — | $160.8M | ||
| Q2 24 | — | $155.9M |
总资产BBNXRVSB
| Q1 26 | $304.4M | — | ||
| Q4 25 | $328.7M | $1.5B | ||
| Q3 25 | $330.0M | $1.5B | ||
| Q2 25 | $330.0M | $1.5B | ||
| Q1 25 | $338.0M | $1.5B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | — | $1.5B | ||
| Q2 24 | — | $1.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-506.0K |
| 自由现金流经营现金流 - 资本支出 | — | $-736.0K |
| 自由现金流率自由现金流/营收 | — | -5.2% |
| 资本支出强度资本支出/营收 | — | 1.6% |
| 现金转化率经营现金流/净利润 | — | -0.37× |
| 过去12个月自由现金流最近4个季度 | — | $20.4M |
8季度趋势，按日历期对齐
经营现金流BBNXRVSB
| Q1 26 | — | — | ||
| Q4 25 | $-8.6M | $-506.0K | ||
| Q3 25 | $-8.7M | $16.8M | ||
| Q2 25 | $-13.6M | $-697.0K | ||
| Q1 25 | $-20.0M | $8.3M | ||
| Q4 24 | — | $2.2M | ||
| Q3 24 | — | $764.0K | ||
| Q2 24 | — | $5.4M |
自由现金流BBNXRVSB
| Q1 26 | — | — | ||
| Q4 25 | $-10.5M | $-736.0K | ||
| Q3 25 | $-10.0M | $16.4M | ||
| Q2 25 | $-15.4M | $-773.0K | ||
| Q1 25 | $-20.3M | $5.6M | ||
| Q4 24 | — | $1.9M | ||
| Q3 24 | — | $-1.4M | ||
| Q2 24 | — | $5.3M |
自由现金流率BBNXRVSB
| Q1 26 | — | — | ||
| Q4 25 | -32.8% | -5.2% | ||
| Q3 25 | -36.7% | 120.1% | ||
| Q2 25 | -66.2% | -5.8% | ||
| Q1 25 | -115.1% | 43.1% | ||
| Q4 24 | — | 15.0% | ||
| Q3 24 | — | -11.3% | ||
| Q2 24 | — | 43.7% |
资本支出强度BBNXRVSB
| Q1 26 | — | — | ||
| Q4 25 | 5.9% | 1.6% | ||
| Q3 25 | 4.7% | 2.9% | ||
| Q2 25 | 7.7% | 0.6% | ||
| Q1 25 | 1.9% | 21.0% | ||
| Q4 24 | — | 2.4% | ||
| Q3 24 | — | 17.3% | ||
| Q2 24 | — | 0.9% |
现金转化率BBNXRVSB
| Q1 26 | — | — | ||
| Q4 25 | — | -0.37× | ||
| Q3 25 | — | 15.25× | ||
| Q2 25 | — | -0.57× | ||
| Q1 25 | — | 7.20× | ||
| Q4 24 | — | 1.79× | ||
| Q3 24 | — | 0.49× | ||
| Q2 24 | — | 5.63× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
